New Enrollment Post-Approval Study of the Argus® II Retinal Prosthesis System

Recruiting in Palo Alto (17 mi)

+16 other locations

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Second Sight Medical Products

No Placebo Group

Trial Summary

What is the purpose of this trial?

This post-approval study is being implemented to monitor the use of Argus II System in a larger US population than available within pre-approval studies. An attempt will be made to include all eligible and willing subjects implanted with Argus II System in the United States.

Research Team

Jessy Dorn, PhD

Principal Investigator

Second Sight Medical Products, Inc.

Eligibility Criteria

Inclusion Criteria

Are adults, age 25 year or older;

Have severe to profound retinitis pigmentosa;

Bare light or no light perception in both eyes; if the patient has no residual light perception, then evidence of intact inner layer retina function must be confirmed;

See 5 more